Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07822477) titled 'A Study to Investigate Safety, Tolerability and Pharmacokinetics of VH5356136 in Adult Participants Without HIV' on Sept. 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: ViiV Healthcare
Condition:
HIV Infections
Intervention:
Drug: VH5356136 Formulation 1
Drug: VH5356136 Formulation 2
Drug: Placebo for VH5356136 Formulation 1
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: November 6, 2026
Target Sample Size: 16...